Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 17795, 2020 10 20.
Artigo em Inglês | MEDLINE | ID: mdl-33082370

RESUMO

Following facial nerve axotomy, nerve function is not fully restored even after reconstruction. This may be attributed to axon degeneration/neuronal death and sustained neuroinflammation. CD38 is an enzyme that catalyses the hydrolysis of nicotinamide adenine dinucleotide (NAD+) and is a candidate molecule for regulating neurodegeneration and neuroinflammation. In this study, we analyzed the effect of CD38 deletion and NAD+ supplementation on neuronal death and glial activation in the facial nucleus in the brain stem, and on axon degeneration and immune cell infiltration in the distal portion of the facial nerve after axotomy in mice. Compared with wild-type mice, CD38 knockout (KO) mice showed reduced microglial activation in the facial nucleus, whereas the levels of neuronal death were not significantly different. In contrast, the axon degeneration and demyelination were delayed, and macrophage accumulation was reduced in the facial nerve of CD38 KO mice after axotomy. Supplementation of NAD+ with nicotinamide riboside slowed the axon degeneration and demyelination, although it did not alter the level of macrophage infiltration after axotomy. These results suggest that CD38 deletion and supplementation of NAD+ may protect transected axon cell-autonomously after facial nerve axotomy.


Assuntos
ADP-Ribosil Ciclase 1/metabolismo , Axônios/fisiologia , Axotomia/métodos , Doenças do Nervo Facial/metabolismo , Nervo Facial/patologia , NAD/metabolismo , ADP-Ribosil Ciclase 1/genética , Animais , Contagem de Células , Células Cultivadas , Suplementos Nutricionais , Modelos Animais de Doenças , Doenças do Nervo Facial/genética , Doenças do Nervo Facial/terapia , Humanos , Camundongos , Camundongos Endogâmicos ICR , Camundongos Knockout , Degeneração Neural
2.
Biol Pharm Bull ; 41(2): 172-181, 2018 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-29187670

RESUMO

Despite the relatively high prevalence of migraine or headache, the pathophysiological mechanisms triggering headache-associated peripheral hypersensitivities, are unknown. Since nitric oxide (NO) is well known as a causative factor in the pathogenesis of migraine or migraine-associated hypersensitivities, a mouse model has been established using systemic administration of the NO donor, nitroglycerin (NTG). Here we tried to investigate the time course development of facial or hindpaw hypersensitivity after repetitive NTG injection. NTG (10 mg/kg) was administrated to mice every other day for nine days. Two hours post-injection, NTG produced acute mechanical and heat hypersensitivity in the hind paws. By contrast, cold allodynia, but not mechanical hypersensitivity, occurred in the facial region. Moreover, this hindpaws mechanical hypersensitivity and the facial cold allodynia was progressive and long-lasting. We subsequently examined whether the depletion of capsaicin-sensitive primary afferents (CSPAs) with resiniferatoxin (RTX, 0.02 mg/kg) altered these peripheral hypersensitivities in NTG-treated mice. RTX pretreatment did not affect the NTG-induced mechanical allodynia in the hind paws nor the cold allodynia in the facial region, but it did inhibit the development of hind paw heat hyperalgesia. Similarly, NTG injection produced significant hindpaw mechanical allodynia or facial cold allodynia, but not heat hyperalgesia in transient receptor potential type V1 (TRPV1) knockout mice. These findings demonstrate that different peripheral hypersensitivities develop in the face versus hindpaw regions in a mouse model of repetitive NTG-induced migraine, and that these hindpaw mechanical hypersensitivity and facial cold allodynia are not mediated by the activation of CSPAs.


Assuntos
Doenças do Nervo Facial/fisiopatologia , Hiperalgesia/fisiopatologia , Transtornos de Enxaqueca/fisiopatologia , Proteínas do Tecido Nervoso/metabolismo , Neurônios Aferentes/efeitos dos fármacos , Doenças do Sistema Nervoso Periférico/fisiopatologia , Canais de Cátion TRPV/metabolismo , Animais , Capsaicina/farmacologia , Temperatura Baixa/efeitos adversos , Diterpenos/toxicidade , Resistência a Medicamentos , Doenças do Nervo Facial/induzido quimicamente , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/patologia , Membro Posterior , Temperatura Alta/efeitos adversos , Hiperalgesia/induzido quimicamente , Hiperalgesia/metabolismo , Hiperalgesia/patologia , Masculino , Camundongos Endogâmicos C57BL , Camundongos Knockout , Transtornos de Enxaqueca/metabolismo , Transtornos de Enxaqueca/patologia , Proteínas do Tecido Nervoso/agonistas , Proteínas do Tecido Nervoso/antagonistas & inibidores , Proteínas do Tecido Nervoso/genética , Neurônios Aferentes/metabolismo , Neurônios Aferentes/patologia , Neurotoxinas/toxicidade , Doadores de Óxido Nítrico/toxicidade , Nitroglicerina/toxicidade , Especificidade de Órgãos , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Doenças do Sistema Nervoso Periférico/metabolismo , Doenças do Sistema Nervoso Periférico/patologia , Fármacos do Sistema Sensorial/farmacologia , Canais de Cátion TRPV/agonistas , Canais de Cátion TRPV/antagonistas & inibidores , Canais de Cátion TRPV/genética
3.
J Diabetes Complications ; 29(5): 629-36, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25891974

RESUMO

Peripheral neuropathy is a frequent complication of diabetes mellitus and a common symptom of neuropathic pain, the mechanism of which is complex and involves both peripheral and central components of the sensory system. The lamina II of the medullary dorsal horn, called the substantia gelatinosa (SG), is well known to be a critical site for processing of orofacial nociceptive information. Although there have been a number of studies done on diabetic neuropathy related to the orofacial region, the action of neurotransmitter receptors on SG neurons in the diabetic state is not yet fully understood. Therefore, we used the whole-cell patch clamp technique to investigate this alteration on SG neurons in both streptozotocin (STZ)-induced diabetic mice and offspring from diabetic female mice. STZ (200 mg/kg)-injected mice showed a small decrease in body weight and a significant increase in blood glucose level when compared with their respective control group. However, application of different concentrations of glycine, gamma-aminobutyric acid (GABA) and glutamate on SG neurons from STZ-injected mice did not induce any significant differences in inward currents when compared to their control counterparts. On the other hand, the offspring of diabetic female mice (induced by multiple injections of STZ (40 mg/kg) for 5 consecutive days) led to a significant decrease in both body weight and blood glucose level compared to the control offspring. Glycine and glutamate responses in the SG neurons of the offspring from diabetic female mice were similar to those of control offspring. However, the GABA response in SG neurons of offspring from diabetic female mice was greater than that of control offspring. Furthermore, the GABA-mediated responses in offspring from diabetic and control mice were examined at different concentrations ranging from 3 to 1,000 µM. At each concentration, the GABA-induced mean inward currents in the SG neurons of offspring from diabetic female mice were larger than those of control mice. These results demonstrate that SG neurons in offspring from diabetic mice are more sensitive to GABA compared to control mice, suggesting that GABA sensitivity may alter orofacial pain processing in offspring from diabetic female mice.


Assuntos
Diabetes Gestacional/fisiopatologia , Neuropatias Diabéticas/metabolismo , Doenças do Nervo Facial/etiologia , Transtornos do Crescimento/etiologia , Substância Gelatinosa/metabolismo , Regulação para Cima , Ácido gama-Aminobutírico/metabolismo , Animais , Diabetes Mellitus Experimental/complicações , Neuropatias Diabéticas/complicações , Neuropatias Diabéticas/fisiopatologia , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/fisiopatologia , Dor Facial/complicações , Dor Facial/etiologia , Feminino , Desenvolvimento Fetal , Ácido Glutâmico/metabolismo , Glicina/metabolismo , Transtornos do Crescimento/metabolismo , Transtornos do Crescimento/fisiopatologia , Masculino , Camundongos Endogâmicos ICR , Gravidez , Gravidez em Diabéticas/fisiopatologia , Estreptozocina , Transmissão Sináptica , Núcleo Inferior Caudal do Nervo Trigêmeo/metabolismo
4.
Exp Neurol ; 264: 26-32, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25446720

RESUMO

Chronically axotomized motoneurons progressively fail to regenerate their axons. Since axonal regeneration is associated with the increased expression of tubulin, actin and GAP-43, we examined whether the regenerative failure is due to failure of chronically axotomized motoneurons to express and sustain the expression of these regeneration associated genes (RAGs). Chronically axotomized facial motoneurons were subjected to a second axotomy to mimic the clinical surgical procedure of refreshing the proximal nerve stump prior to nerve repair. Expression of α1-tubulin, actin and GAP-43 was analyzed in axotomized motoneurons using in situ hybridization followed by autoradiography and silver grain quantification. The expression of these RAGs by acutely axotomized motoneurons declined over several months. The chronically injured motoneurons responded to a refreshment axotomy with a re-increase in RAG expression. However, this response to a refreshment axotomy of chronically injured facial motoneurons was less than that seen in acutely axotomized facial motoneurons. These data demonstrate that the neuronal RAG expression can be induced by injury-related signals and does not require acute deprivation of target derived factors. The transient expression is consistent with a transient inflammatory response to the injury. We conclude that transient RAG expression in chronically axotomized motoneurons and the weak response of the chronically axotomized motoneurons to a refreshment axotomy provides a plausible explanation for the progressive decline in regenerative capacity of chronically axotomized motoneurons.


Assuntos
Doenças do Nervo Facial , Proteína GAP-43/metabolismo , Regulação da Expressão Gênica/fisiologia , Neurônios Motores/metabolismo , Regeneração Nervosa/fisiologia , Tubulina (Proteína)/metabolismo , Animais , Axotomia , Modelos Animais de Doenças , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/patologia , Doenças do Nervo Facial/fisiopatologia , Proteína GAP-43/genética , Masculino , Neurônios Motores/patologia , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Tubulina (Proteína)/genética
5.
J Comp Neurol ; 521(14): 3217-25, 2013 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-23695797

RESUMO

Exogenous ciliary neurotrophic factor (CNTF) promotes motor neuron (MN) survival following trauma and in genetic models of MN disease. Unconditional disruption of the mouse CNTF receptor α (CNTFRα) gene leads to MN loss, demonstrating a developmental role for endogenous CNTF receptor signaling. These data also suggest that CNTF receptors may promote adult MN survival and that appropriately manipulating the receptors could effectively treat adult MN disorders. This effort would greatly benefit from a better understanding of the roles played by CNTF receptors in adult MNs. We have previously found that adult onset disruption of CNTFRα in facial MNs of "floxed CNTFRα" mice by AAV-Cre vector injection leads to significantly more MN loss than in identically treated controls. While indicating that CNTF receptors can promote adult MN survival, the data did not distinguish between potential roles in MN maintenance versus roles in protecting MNs from the injection associated trauma or the toxicity of the chronic Cre recombinase (Cre) produced by the AAV-Cre. Here we used an inducible Cre gene construct to produce adult-onset CNTFRα disruption in facial MNs without the traumatic and toxic effects of the AAV-Cre procedure. The MNs survive without CNTFRα, even when challenged by facial nerve crush or the injection-associated trauma, thereby suggesting, in conjunction with our previous study, that endogenous CNTF receptor signaling can protect MNs against toxic insult, such as that produced by chronic Cre. The data also indicate that in vivo CNTF receptors play very different roles in adult and embryonic MNs.


Assuntos
Subunidade alfa do Receptor do Fator Neutrófico Ciliar/metabolismo , Doenças do Nervo Facial/patologia , Regulação da Expressão Gênica/fisiologia , Traumatismos Cranianos Penetrantes/patologia , Neurônios Motores/patologia , Adenoviridae/genética , Análise de Variância , Animais , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Contagem de Células , Sobrevivência Celular/genética , Subunidade alfa do Receptor do Fator Neutrófico Ciliar/genética , Modelos Animais de Doenças , Doenças do Nervo Facial/metabolismo , Regulação da Expressão Gênica/genética , Traumatismos Cranianos Penetrantes/metabolismo , Proteínas Luminescentes/genética , Proteínas Luminescentes/metabolismo , Camundongos , Camundongos Transgênicos , Neurônios Motores/metabolismo , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Tamoxifeno/farmacologia
7.
Muscle Nerve ; 41(5): 679-84, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20229579

RESUMO

Hereditary amyloidosis of the Finnish type (HAF, or familial amyloid polyneuropathy type IV) is an autosomal dominant disease that has been described most commonly in the Finnish population but has also been found in some other countries. Herein we report the first German family whose members suffer from this condition. There are no known Finnish ancestors. We performed clinical and electrophysiological examinations in 22 members of this family. All symptomatic family members suffered from facial palsy, and most of them had peripheral neuropathy. One patient had confirmed corneal lattice dystrophy. Additional symptoms were hypoglossal nerve involvement in 5 patients and oculomotor nerve palsy in 1 patient. The lips of all older patients appeared thickened. The causative G654A mutation in the gelsolin gene was found in all affected family members.


Assuntos
Neuropatias Amiloides Familiares/fisiopatologia , Doenças dos Nervos Cranianos/fisiopatologia , Doenças do Sistema Nervoso Periférico/fisiopatologia , Adolescente , Adulto , Idoso , Neuropatias Amiloides Familiares/diagnóstico , Neuropatias Amiloides Familiares/genética , Distrofias Hereditárias da Córnea/diagnóstico , Distrofias Hereditárias da Córnea/metabolismo , Distrofias Hereditárias da Córnea/fisiopatologia , Doenças dos Nervos Cranianos/diagnóstico , Doenças dos Nervos Cranianos/genética , Nervos Cranianos/metabolismo , Nervos Cranianos/fisiopatologia , Análise Mutacional de DNA , Avaliação da Deficiência , Eletrodiagnóstico , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/fisiopatologia , Feminino , Finlândia , Gelsolina/genética , Marcadores Genéticos/genética , Testes Genéticos , Genótipo , Alemanha , Humanos , Doenças do Nervo Hipoglosso/metabolismo , Doenças do Nervo Hipoglosso/fisiopatologia , Padrões de Herança/genética , Masculino , Pessoa de Meia-Idade , Mutação/genética , Exame Neurológico , Doenças do Nervo Oculomotor/diagnóstico , Doenças do Nervo Oculomotor/metabolismo , Doenças do Nervo Oculomotor/fisiopatologia , Nervos Periféricos/metabolismo , Nervos Periféricos/fisiopatologia , Doenças do Sistema Nervoso Periférico/diagnóstico , Doenças do Sistema Nervoso Periférico/genética , Adulto Jovem
8.
Surg Neurol ; 70(2): 190-3, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17976702

RESUMO

BACKGROUND: In an RCT of PDT in the treatment of malignant gliomas, 3 patients developed cranial neuropathies after photoillumination. We are aware of no previous reports on cranial neuropathy after intracranial PDT. METHODS: In a cohort of 80 patients, there were 41 men and 39 women; 47 were newly diagnosed and 33 had recurrent tumors. All patients underwent surgical tumor extirpation. There were 77 malignant gliomas, 2 meningiomas, and 1 metastatic tumor. The tumor locations were as follows: 39 frontal, 25 temporal, 12 parietal, and 4 occipital. Of the 25 patients with temporal lobe tumors, 18 received PDT. RESULTS: Three of the 18 patients with temporal lobe tumors developed cranial neuropathies after PDT. The floor of the middle fossa received photoillumination in all 3 patients. This complication was not seen in any other patient with tumors in the frontal, parietal, or occipital regions, or patients with temporal lobe tumors who did not receive PDT. The first patient developed seventh nerve paresis and hypoesthesia in fifth nerve distribution, which resolved only partially. The second patient developed a seventh nerve paresis that resolved completely. The third patient developed transient neuralgic pain in the trigeminal nerve distribution. CONCLUSIONS: Cranial neuropathies could be the result of photoillumination of fifth and seventh cranial nerves during PDT of the temporal fossa. We recommend shielding of the middle fossa floor during PDT.


Assuntos
Doenças dos Nervos Cranianos/induzido quimicamente , Éter de Diematoporfirina/efeitos adversos , Glioma/tratamento farmacológico , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Fotoquimioterapia/efeitos adversos , Neoplasias Supratentoriais/tratamento farmacológico , Idoso , Antineoplásicos/efeitos adversos , Fossa Craniana Média/patologia , Doenças dos Nervos Cranianos/metabolismo , Doenças dos Nervos Cranianos/fisiopatologia , Nervo Facial/anatomia & histologia , Nervo Facial/efeitos dos fármacos , Nervo Facial/fisiopatologia , Doenças do Nervo Facial/induzido quimicamente , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/fisiopatologia , Feminino , Glioma/metabolismo , Humanos , Luz/efeitos adversos , Masculino , Pessoa de Meia-Idade , Doenças do Sistema Nervoso Periférico/metabolismo , Doenças do Sistema Nervoso Periférico/fisiopatologia , Estimulação Luminosa/efeitos adversos , Cuidados Pré-Operatórios/normas , Neoplasias Supratentoriais/metabolismo , Lobo Temporal/patologia , Lobo Temporal/fisiopatologia , Nervo Trigêmeo/anatomia & histologia , Nervo Trigêmeo/efeitos dos fármacos , Nervo Trigêmeo/fisiopatologia , Doenças do Nervo Trigêmeo/induzido quimicamente , Doenças do Nervo Trigêmeo/metabolismo , Doenças do Nervo Trigêmeo/fisiopatologia
9.
Glia ; 56(3): 331-41, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18098126

RESUMO

Microglia is activated by brain injury. They migrate in response to ATP and although adenosine alone has no effect on wild type microglial migration, we show that inhibition of adenosine receptors impedes ATP triggered migration. CD39 is the dominant cellular ectonucleotidase that degrades nucleotides to nucleosides, including adenosine. Importantly, ATP fails to stimulate P2 receptor mediated migration in cd39(-/-) microglia. However, the effects of ATP on migration in cd39(-/-) microglia can be restored by co-stimulation with adenosine or by addition of a soluble ectonucleotidase. We also tested the impact of cd39-deletion in a model of ischemia, in an entorhinal cortex lesion and in the facial nucleus after facial nerve lesion. The accumulation of microglia at the pathological sites was markedly decreased in cd39(-/-) animals. We conclude that the co-stimulation of purinergic and adenosine receptors is a requirement for microglial migration and that the expression of cd39 controls the ATP/adenosine balance.


Assuntos
Antígenos CD/fisiologia , Apirase/fisiologia , Movimento Celular/genética , Microglia/fisiologia , Receptores Purinérgicos P2/fisiologia , Nucleotídeos de Adenina/farmacologia , Animais , Animais Recém-Nascidos , Apirase/deficiência , Apirase/farmacologia , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patologia , Movimento Celular/efeitos dos fármacos , Células Cultivadas , Citocinas/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Interações Medicamentosas , Córtex Entorrinal/patologia , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/patologia , Doenças do Nervo Facial/fisiopatologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Microglia/patologia , Microglia/ultraestrutura , Técnicas de Patch-Clamp/métodos , Receptores Purinérgicos P1/deficiência
10.
Mol Cell Neurosci ; 33(4): 401-11, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17055293

RESUMO

Activation of microglia by LPS leads to an induction of cytokine and NO release, reduced proliferation and increased outward K(+) conductance, the latter involving the activation of Kv1.5 and Kv1.3 channels. We studied the role of these channels for microglial function using two strategies to interfere with channel expression, a Kv1.5 knockout (Kv1.5(-/-)) mouse and an antisense oligonucleotide (AO) approach. The LPS-induced NO release was reduced by AO Kv1.5 and completely absent in the Kv1.5(-/-) animal; the AO Kv1.3 had no effect. In contrast, proliferation was augmented with both, loss of Kv1.3 or Kv1.5 channel expression. After facial nerve lesion, proliferation rate was higher in Kv1.5(-/-) animals as compared to wild type. Patch clamp experiments confirmed the reduction of the LPS-induced outward current amplitude in Kv1.5(-/-) microglia as well as in Kv1.5- or Kv1.3 AO-treated cells. Our study indicates that induction of K(+) channel expression is a prerequisite for the full functional spectrum of microglial activation.


Assuntos
Canal de Potássio Kv1.3/fisiologia , Canal de Potássio Kv1.5/fisiologia , Microglia/fisiologia , Animais , Encéfalo/citologia , Bromodesoxiuridina/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Quimiocinas/metabolismo , Citocinas/metabolismo , Relação Dose-Resposta à Radiação , Estimulação Elétrica/métodos , Embrião de Mamíferos , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/patologia , Imuno-Histoquímica/métodos , Canal de Potássio Kv1.3/química , Canal de Potássio Kv1.5/química , Canal de Potássio Kv1.5/genética , Lipopolissacarídeos/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Potenciais da Membrana/efeitos da radiação , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Microglia/efeitos dos fármacos , Óxido Nítrico/metabolismo , Oligodesoxirribonucleotídeos Antissenso/farmacologia , Técnicas de Patch-Clamp/métodos , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
11.
Neuroscience ; 140(1): 87-100, 2006 Jun 19.
Artigo em Inglês | MEDLINE | ID: mdl-16631314

RESUMO

Oligodendrocyte precursor cells recognized with the NG2 antibody respond rapidly to CNS injuries with hypertrophy and upregulation of the NG2 chondroitin sulfate proteoglycan within 24 h. These cells participate in glial scar formation, remaining around the injury site for several weeks. After injury, reactive oligodendrocyte precursor cells increase their production of several chondroitin sulfate proteoglycans, including NG2: this cell type thus represents a component of the inhibitory environment that prevents regeneration of axons in the injured CNS. This study analyzes factors that activate oligodendrocyte precursor cells. Both microglia and astrocytes become reactive around motor neurons following peripheral nerve lesions. We show that oligodendrocyte precursor cells do not hypertrophy or increase NG2 levels after these lesions. Those lesions that cause an oligodendrocyte precursor cell reaction generally open the blood-brain barrier. We therefore opened the blood-brain barrier with microinjections of vascular endothelial growth factor or lipopolysaccharide to the rat and mouse brain, and examined oligodendrocyte precursor cell reactivity after 24 h. Both treatments led to increases in NG2 and hypertrophy of oligodendrocyte precursor cells. Of directly injected blood components serum and thrombin were without effect, while platelets and macrophages activated oligodendrocyte precursor cells. We tested the effects of a range of injury-related cytokines, of which tumor necrosis factor alpha; interleukin-1; transforming growth factor beta; interferon gamma had effects on oligodendrocyte precursor cells. Oligodendrocyte precursor cell chemokines, and mitogens did not increase NG2 levels.


Assuntos
Plaquetas/fisiologia , Citocinas/farmacologia , Macrófagos/fisiologia , Oligodendroglia/metabolismo , Neuropatia Ciática/patologia , Células-Tronco/metabolismo , Animais , Antígenos/metabolismo , Axotomia/métodos , Barreira Hematoencefálica/efeitos dos fármacos , Barreira Hematoencefálica/fisiopatologia , Encéfalo/citologia , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Antígeno CD11b/metabolismo , Linhagem Celular , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/patologia , Feminino , Lateralidade Funcional , Expressão Gênica/efeitos dos fármacos , Imuno-Histoquímica/métodos , Camundongos , Microinjeções/métodos , Proteoglicanas/metabolismo , Ratos , Ratos Sprague-Dawley , Neuropatia Ciática/fisiopatologia
12.
Neurol Res ; 28(8): 794-801, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17288733

RESUMO

OBJECTIVE: The aim of this study is to evaluate the role of extracellular matrix components in nerve regeneration. Matrigel, a complex of extracellular matrix components such as laminin (the most abundant) heparan sulphate proteoglycans (HSPG), type IV collagen and fibronectin, was used. METHODS: Forty male rabbits, which had undergone section of the right facial nerve, were later treated by reinnervation through an artificial graft of expanded polytetrafluoroethylene (ePTFE). In 20 animals the tubes of ePTFE were filled with Matrigel; in 20 control animals the tubes were filled with saline solution. RESULTS: The Matrigel group showed a better axonal organization and a significantly higher number of regenerated axons in the early phases (at days 15 and 30 respectively) than the control group, whereas the difference of the axons number at day 60 was less significant; besides, the axon diameter and the myelin thickness were not significantly improved by Matrigel. DISCUSSION: Our data suggest that Matrigel is an important factor in promoting and enhancing the early phases of the regeneration after nerve injuries. Tree neurite promoting agents, such as laminin, fibronectin and collagen, allow a more systematic and agonized regeneration. Extracellular matrix components may represent a direction guidance for axonal pathway.


Assuntos
Proteínas da Matriz Extracelular/uso terapêutico , Matriz Extracelular/fisiologia , Doenças do Nervo Facial/fisiopatologia , Regeneração Nervosa/fisiologia , Animais , Axônios/patologia , Materiais Biocompatíveis/uso terapêutico , Colágeno/uso terapêutico , Modelos Animais de Doenças , Combinação de Medicamentos , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/terapia , Laminina/uso terapêutico , Masculino , Microscopia Eletrônica de Transmissão/métodos , Bainha de Mielina/efeitos dos fármacos , Bainha de Mielina/patologia , Regeneração Nervosa/efeitos dos fármacos , Politetrafluoretileno/uso terapêutico , Proteoglicanas/uso terapêutico , Coelhos , Fatores de Tempo
13.
Eur J Neurosci ; 21(2): 363-77, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15673436

RESUMO

We have investigated the effect of JNK1 ko, JNK2 ko, JNK3 ko, JNK2+3 ko and c-JunAA mutation on neuronal survival in adult transgenic mice following ischemia, 6-hydroxydopamine induced neurotoxicity, axon transection and kainic acid induced excitotoxicity. Deletion of JNK isoforms indicated the compartment-specific expression of JNK isoforms with 46-kDa JNK1 as the main phosphorylated JNK isoform. Permanent occlusion of the MCA significantly enlarged the infarct area in JNK1 ko, which showed an increased expression of JNK3 in the penumbra. Survival of dopaminergic neurons in the substantia nigra compacta (SNC) following intrastriatal injection of 6-hydroxydopamine was transiently improved in JNK3 ko and c-JunAA mice after 7 days, but not 60 days. Following transection of the medial forebrain bundle, however, JNK3 ko conferred persisting neuroprotection of axotomised SNC neurons. None of the JNK ko and c-JunAA mutation affected the survival of facial motoneurons following peripheral axotomy when investigated after 90 days. Finally, we determined the impact of JNK ko on the survival of animals and the degeneration of hippocampal neurons following kainic acid. JNK3 ko mice were substantially resistant against and survived kainic acid-induced seizures. JNK3 ko and JNK1 ko showed a nonsignificant tendency for decreased or increased death of hippocampal neurons, respectively. Surprisingly, the deletion of a single JNK isoform did not attenuate the immunocytochemical signal of phosphorylated c-Jun irrespective on the experimental set-up. This comprehensive study provides novel insights into the context-dependent physiological and pathological functions of JNK isoforms.


Assuntos
Encéfalo/metabolismo , Regulação da Expressão Gênica , Isoenzimas/fisiologia , Proteínas Proto-Oncogênicas c-jun/fisiologia , Animais , Denervação Autônoma/métodos , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Western Blotting/métodos , Encéfalo/anatomia & histologia , Encéfalo/efeitos dos fármacos , Lesões Encefálicas/induzido quimicamente , Lesões Encefálicas/metabolismo , Lesões Encefálicas/fisiopatologia , Contagem de Células/métodos , Morte Celular/efeitos dos fármacos , Ativação Enzimática , Doenças do Nervo Facial/metabolismo , Doenças do Nervo Facial/fisiopatologia , Feminino , Lateralidade Funcional/fisiologia , Regulação da Expressão Gênica/efeitos dos fármacos , Imuno-Histoquímica/métodos , Marcação In Situ das Extremidades Cortadas/métodos , Infarto da Artéria Cerebral Média/metabolismo , Infarto da Artéria Cerebral Média/fisiopatologia , Isoenzimas/genética , Ácido Caínico , Masculino , Feixe Prosencefálico Mediano/lesões , Feixe Prosencefálico Mediano/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Atividade Motora/efeitos dos fármacos , Atividade Motora/genética , Neurônios/metabolismo , Oxidopamina , Fosforilação , Proteínas Proto-Oncogênicas c-jun/genética , Serina/imunologia , Coloração e Rotulagem/métodos , Fatores de Tempo , Tirosina 3-Mono-Oxigenase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...